Trials / Active Not Recruiting
Active Not RecruitingNCT03208374
Exercise Exposure Data Collection in Patients Undergoing Tumor Molecular Profiling
- Status
- Active Not Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,600 (actual)
- Sponsor
- Memorial Sloan Kettering Cancer Center · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Accepted
Summary
This study will recruit approximately 5,000 patients with histologically confirmed cancer who have successfully completed MSK-IMPACT panel testing and collect information about tumor genetic results and patient exercise behavior history. The purpose of the study is to create a registry to collect exercise behavior history in patients who had IMPACT genetic panel testing on protocol IRB #12-245 "Genomic Profiling in Cancer Patients", IRB #06-107 "Storage and Research Use of Human Biospecimens," or IRB #09-141 "Collection of Human Biological Specimens from Patients for Research Studies." The investigators want to find a way to create an exercise database. This database will collect information about tumor genetic results and patient exercise behavior history.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| BEHAVIORAL | Prior Exercise Behavior Questions - Harvard Health Professionals Exercise Questionnaire | Participants will be asked how often on average over the year prior to their most recent diagnosis they participated in walking or hiking; jogging; running; calisthenics, aerobics, rowing, Nordic track; bicycling; tennis, squash, racquetball; lap swimming; weightlifting; and other aerobic exercise (e.g. heavy outdoor work), as well as their usual walking pace and flights of stairs climbed daily over the past 12 months prior to diagnosis. |
| BEHAVIORAL | Current Exercise Behavior Questions: International Physical Activity Questionnaire Short Form (IPAQ SF) | The purpose of this questionnaire is to provide common instruments that can be used to obtain internationally comparable data on exercise exposure in adults aged 15 to 80 years old. |
Timeline
- Start date
- 2017-06-27
- Primary completion
- 2026-06-01
- Completion
- 2026-06-01
- First posted
- 2017-07-05
- Last updated
- 2025-07-04
Locations
7 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT03208374. Inclusion in this directory is not an endorsement.